๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Capillary separations enabling tissue proteomics-based biomarker discovery

โœ Scribed by Tong Guo; Cheng S. Lee; Weijie Wang; Don L. DeVoe; Brian M. Balgley


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
536 KB
Volume
27
Category
Article
ISSN
0173-0835

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prostate carcinoma tissue proteomics for
โœ Yaxin Zheng; Ye Xu; Bin Ye; Junyi Lei; Michael H. Weinstein; Michael P. O'Leary; ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 249 KB

## Abstract ## BACKGROUND The advent of the prostateโ€specific antigen (PSA) test has had a profound impact on the diagnosis and treatment of prostate carcinoma. However, the use of PSA levels alone for screening for prostate carcinoma was compromised by the variations in the amount of PSA produced

Recent advances in capillary electrophor
โœ Xueping Fang; Brian M. Balgley; Cheng S. Lee ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 510 KB

## Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery A compelling need exists for the development of technologies that facilitate and accelerate the discovery of novel protein biomarkers with therapeutic and diagnostic potential. The inherent disadvant

Tissue culture-based breast cancer bioma
โœ Vathany Kulasingam; Eleftherios P. Diamandis ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 94 KB

## Abstract Current cancer biomarkers suffer from low diagnostic sensitivity and specificity and have not yet made a major impact on reducing cancer burden. Proteomic methods based on mass spectrometry have matured significantly over the past few years and hold promise to deliver candidate markers

Fractionation of the human plasma proteo
โœ Andrรกs Kovรกcs; Edit Sperling; Jรณzsef Lรกzรกr; Attila Balogh; Jรกnos Kรกdas; รkos Sze ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 276 KB

## Abstract mAb proteomics, a reversed biomarker discovery approach, is a novel methodology to recognize the proteins of biomarker potential, but requires subsequent antigen identification steps. While in case of highโ€abundant proteins, it generally does not represent a problem, for medium or lower